• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Palisade Bio Inc (NQ: PALI )

    2.570 +0.030 (+1.18%)
    Streaming Delayed Price Updated: 11:55 AM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Palisade Bio Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    PALI Stock Earnings: Palisade Bio Misses EPS for Q2 2024
    PALI stock results show that Palisade Bio missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    PALI Stock Earnings: Palisade Bio Beats EPS for Q1 2024
    PALI stock results show that Palisade Bio beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    US Stocks Mixed; Amazon Posts Upbeat Earnings
    Via Benzinga
    Looking Into Palisade Bio's Recent Short Interest
    Via Benzinga
    Why Is Palisade Bio (PALI) Stock Up 100% Today?
    Palisade Bio is benefiting from a trio of positive news items, including encouraging preclinical data. Now PALI stock is blasting higher. 
    Via InvestorPlace
    Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Crude Oil Moves Higher; General Motors Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Dow Jumps Over 200 Points; US Services PMI Falls In April
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Palisade Bio Stock Is Up Today
    Palisade Bio entered into a collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative colitis (UC) therapy and provides the company access to advanced... 
    Via Benzinga
    US Stocks Higher; PepsiCo Posts Upbeat Earnings
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning! 
    Via InvestorPlace
    S&P 500 Edges Lower; PacBio Shares Plunge
    U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.02% to 37,741.96 while the NASDAQ fell 0.20% to 15,853.39. The S&P 500 also... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Gold Moves Higher; Morgan Stanley Earnings Top Views
    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded up 0.13% to 37,784.21 while the NASDAQ fell 0.20% to 15,853.34. The S&P 500... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Live Nation Antitrust Probe Rattles LYV Stock. What to Know.
    Live Nation Entertainment stock is falling on Tuesday as LYV investors react to reports of an antitrust probe from the Justice Department. 
    Via InvestorPlace
    Why Is Peraso (PRSO) Stock Up 53% Today?
    Peraso stock is climbing on Tuesday after the company announced a deal for its X710 chipset that has PRSO shares seeing heavy trading. 
    Via InvestorPlace
    Why Palisade Bio Stock Is Soaring Today
    Palisade Bio shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bioactivation of PALI-2108. Palisade Bio said the findings demonstrated... 
    Via Benzinga
    Why Is Jaguar Health (JAGX) Stock Up 44% Today?
    Jaguar Health stock is up on Tuesday as JAGX investors celebrate the company signing a new license agreement for a chemo mouth treatment. 
    Via InvestorPlace
    Why Is Palisade Bio (PALI) Stock Up 57% Today?
    Palisade Bio stock is up on Tuesday after the company announced positive data for its ulcerative colitis treatment PALI-2108. 
    Via InvestorPlace
    Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
    U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.35% to 37,865.71 while the NASDAQ fell... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    PALI Stock Earnings: Palisade Bio Beats EPS for Q4 2023
    PALI stock results show that Palisade Bio beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.